We’re dissecting a high-stakes corporate thriller set at the height of a global health crisis. We're looking at Chembio Diagnostics—a company that promised a scientific breakthrough only to be met with FDA revocations and SEC charges. Join us as we peel back the layers of technology, federal procurement, and the thin line between emergency innovation and corporate deception.

Read the full post: https://doomscrollnews.com/chembio-diagnostics-the 2020 public health event-test-failure-analysis/